Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−470 KRW
−3.18 B KRW
348.99 B KRW
23.30 M
About ACCESS BIO, INC.
Sector
Industry
CEO
Young-Ho Choi
Website
Headquarters
Somerset
Founded
2002
ISIN
KR8840090003
FIGI
BBG004FMF955
Access Bio, Inc. engages in the research, development, and manufacture of in-vitro diagnostic tests, immunochemical diagnosis, biosensor, and molecular diagnostic technology. Its products are diagnostic reagents that diagnose infectious diseases such as malaria, influenza, and Coronavirus. The company was founded on September 27, 2002 and is headquartered in Somerset, NJ.
Displays a symbol's price movements over previous years to identify recurring trends.